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Exosomes participate in intercellular messaging by transporting bioactive lipid-, protein- and 
RNA-molecules and -complexes. The contents of the exosomes reflect the physiological status of 
an individual making exosomes promising targets for biomarker analyses. In the present study we 
extracted exosome microRNAs (exomiRs) from serum samples of premenopausal women (n = 8) and 
monozygotic postmenopausal twins (n = 10 female pairs), discordant for the use of estrogenic hormone 
replacement therapy (HRT), in order to see whether the age or/and the use of HRT associates with 
exomiR content. A total of 241 exomiRs were detected by next generation sequencing, 10 showing age, 
14 HRT and 10 age +HRT -related differences. When comparing the groups, differentially expressed 
miRs were predicted to affect cell proliferation processes showing inactivation with younger age and 
HRT usage. MiR-106-5p, -148a-3p, -27-3p, -126-5p, -28-3p and -30a-5p were significantly associated 
with serum 17β-estradiol. MiRs formed two hierarchical clusters being indicative of positive or negative 
health outcomes involving associations with body composition, serum 17β-estradiol, fat-, glucose- and 
inflammatory markers. Circulating exomiR clusters, obtained by NGS, could be used as indicators of 
metabolic and inflammatory status affected by hormonal changes at menopause. Furthermore, the 
individual effects of HRT-usage could be evaluated based on the serum exomiR signature.
MicroRNAs (miRs) are a class of epigenetic regulators, small non-coding RNAs, which bind to their target 
mRNAs leading to RNA silencing and further to translational suppression. MiRs are localized in various cell 
types as well as in all body fluids. To date it has been shown that circulating miRs are either attached to vesicle free 
protein complexes, such as argonaute proteins (Ago 1–4)1,2 or high density lipoprotein (HDL) molecules3, local-
ized inside the apoptotic bodies4 or exosomes5. Especially exosome miRs (exomiRs) are known to be relatively 
stable in the circulation.
Exosomes are small (<100 nm in diameter) spherical bilayer proteolipid vesicles produced by various cell 
types under both normal and pathological conditions. They bud from the late endosomes in the cytoplasm form-
ing multivesicular bodies (MVB) and either remain in the cells they are formed or are fused with the plasma 
membrane and exported to the extracellular matrix or further to the circulation6. It has been shown that exosomes 
consist of lipids, proteins and different sized RNA molecules including miRs5,7. The content of the exosomes is 
affected by their source and also supposedly due to the physiological condition of the exosome secreting cell. 
Quite recent studies have demonstrated that the messages, delivered by the secreted exosomal RNAs, can gener-
ate changes in the gene expressions and protein concentrations of the recipient cells, suggesting the functionality 
of the exosome content in the target cells5. Especially the immuno-stimulating role of the exosomes has been 
emphasized e.g. by showing that dendritic cells communicate via so called exosome-miR shuttles in mice8.
Estrogens, female sex steroid hormones, have broad systemic effects on different cell types through their 
receptors. As known, the levels of systemic estrogens, especially 17β -estradiol (E2), change dramatically at the 
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time of menopause in women. Estrogen sensitivity of miR regulation and their expression in different cell types 
has been recently demonstrated in several studies9–13. Our previous studies have shown that circulating cell free 
miRs, including miR-21 and miR-146a differ between postmenopausal genetically identical twin sisters who are 
discordant for the estrogen based hormone replacement therapy (HRT) suggesting that systemic estrogen levels 
affect miR profile14.
A very recently published study demonstrated an association between accelerated aging, measured by the 
epigenetic age i.e. DNA methylation status of blood, and early onset of menopause15. In the present study, we 
investigated whether the age or/and the use of postmenopausal HRT associates with the miR content of the 
circulating exosomes. We extracted exosomes from the serum of healthy premenopausal women (n = 8) not 
using external estrogen products and from healthy postmenopausal monozygotic (MZ) twin sisters discordant 
for the use of HRT (n = 10 pairs). Next generation sequencing (NGS) was used to analyze the exomiR content 
and CAP-miRSEQ pipeline together with Poisson-normal regression model to identify specific miRs with dif-
ferential expression pattern. Our results indicated that specific miRs differ in terms of the age of the sample 
donator and HRT treatment. These miRs have been shown to function as regulators of cellular homeostasis. 
Hierarchical clustering analysis revealed two miR-clusters, the other indicating negative association with E2 par-
allel to positive association with markers of adiposity and inflammation and the other being opposite in the 
associations with E2 and metabolic health markers. These results suggest that female E2 status may be a mediator 
of the change in exomiR content that in turn is associated with change in health metabolic status known to occur 
within menopause.
Results
Participant characteristics. Participant anthropometrics and measured blood characteristics as well as 
group differences are presented in the Table 1. All groups differed significantly from each other in serum E2 
and follicle stimulating hormone (FSH) levels those being highest (E2) and lowest (FSH) among premenopausal 
women as expected. Waist circumference was significantly lower among premenopausal women compared to 
both postmenopausal groups. Fat percentage was significantly lower in postmenopausal HRT users compared to 
their co-twins. Serum TNF-α and plasma glucose concentrations were also significantly lower among premeno-
pausal women in comparison to postmenopausal women.
ExomiR profile and differentially expressed miRs in NGS. The functionality of the used exosome 
extraction method was demonstrated by electron microscope imaging (Fig. 1, a representative image obtained 
from the serum exosomes of a postmenopausal HRT user). Most of the detected lipid vesicles were in normal 
range for exosomes being under 100 nm in diameter. The exosome quantity, measured by esterase activity, 
showed no differences between the studied groups (Pre = 17566 ± 1196 RFU/μ g, HRT = 17876 ± 5801 RFU/μ g, 
No HRT = 16303 ± 4370 RFU/μ g, P = 0.610–0.925). Altogether, 241 different known miRs were detected in the 
serum exosomes by NGS. The processed sequencing reads are presented in Supplementary data (S1). The most 
abundant miRs of the exosome cargo include miR-486-5p, -92a-3p, -16-5p, -451a, -22-3p and -423-5p together 
covering up to 84.6% of the exomiR content (Fig. 2).
The miR read counts from the differentially expressed miRs are presented in Table 2. Altogether, 21 miRs 
had significant differential expression pattern (p-value with false discovery rate (FDR) correction, P < 0.05) in 
NGS either in one, two or three group comparisons (postmenopausal No HRT group vs. premenopausal group, 
postmenopausal HRT-user group vs. premenopausal group or postmenopausal HRT-users vs. postmenopau-
sal non-using co-twins). MiR-126-5p, -142-5p, -484 and -10b-5p were differentially expressed between all the 
studied groups (P < 0.001) showing age- and HRT-use associated differences. MiR-27b-3p, -10a-5p, -215-5p and 
-144-5p were differentially expressed between both postmenopausal groups vs premenopausal women showing 
age-associated differences with or without HRT (P < 0.001). MiR-148-3p and -28-3p were differentially expressed 
between postmenopausal No HRT group vs premenopausal women (P = 0.008, P = 0.009, respectively) and miR-
375 and -186-5p between postmenopausal HRT group vs premenopausal women (P = 0.045, P < 0.001, respec-
tively). MiR-532-5p, -1285-3p, -30a-5p, -3688-3p, -29b-3p, -106b-5p, -29c-3p, -1306-5p, -148a-3p and -301a were 
differentially expressed between HRT users and their non-using co-twins suggesting association between HRT- 
use and miR expression (P < 0.001, P < 0.001, P = 0.001, P = 0.016, P = 0.029, P = 0.029, P = 0.033, P = 0. 036, 
P = 0.049, P = 0.049, respectively).
Functional network analysis. All sequenced miRs were included in the analyses to identify the most 
prominent networks by explorative comparison analyses by Ingenuity pathway tools (IPA) (Fig. 3). No cut-offs 
for p-values were used. The age comparison between postmenopausal women without HRT and premenopausal 
women suggested that estrogen receptors (ESRs) and insulin are predicted to be the biggest upstream regulators 
of the miRs in the network. Six of the differentially expressed miRs (FDR < 0.05) listed in Table 2 were involved 
in the network and highlighted in the figure. The comparison between postmenopausal HRT users and premen-
opausal women involved also ESRs and insulin as upstream regulators but only two of the differentially expressed 
miRs, miR-27b-3p and miR-126-5p. The comparison between the postmenopausal twin sisters involved five of 
the differentially expressed miRs out of which four are predicted to be regulated by insulin. In addition, miR-
106b-5p was predicted to have VEGF and SMAD6/7 as upstream regulators and miR-30a-5p chorionic gonado-
tropin (Cg).
To focus on the most significant miRs, comparison analysis was performed to differentially expressed miRs 
(cut-off P < 0.05) by IPA, including all the three group comparisons (Fig. 4). Cell proliferation was the most 
significant downstream target process predicted to be affected in all the comparisons. Comparisons between 
premenopausal and both postmenopausal groups included the same miRs (miR-27b-3p, -215-5p, -126-5p and 
-10a-5p), except for miR-148a-3p which was included only in the premenopausal vs postmenopausal No HRT 
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group network. Higher age (or postmenopausal status) was predicted to up-regulate the cell proliferation pathway 
whether using HRT or not. Other set of miRs (miR-29b-3p, -106b-5p, -142-5p, and -1285-3p) were shown to have 
an effect when comparing the postmenopausal co-twins with each other. In this comparison, the use of HRT was 
predicted to down-regulate the cell proliferation pathway. Figure 4 shows the main networks for differentially 
expressed miRs identified by IPA with its annotation as the top diseases and functions and the interacting mole-
cules i.e., potential miR targets as well as miRs included in the network.
Associations of NGS reads with serum E2 and other variables. The associations of the differentially 
expressed miRs with serum E2 concentration, body composition and fat-, glucose- and inflammation related 
markers are visualized as a correlation heatmap (Fig. 5). The p-values, FDR-values and correlation coefficients 
are presented in Supplementary data (S2). Heatmap reveals hierarchically clustered information about the asso-
ciations of the selected miRs with other measured variables. First of all, six miRs from the differentially expressed 
NGS results were significantly (FDR < 0.05) associated with serum E2. MiR-106b-5p was positively associated 
with serum E2 concentration, while other miRs, miR-148a-3p, -27-3p, -126-5p, -28-3p and -30a-5p were neg-
atively associated with serum E2 concentration. In addition, miR-144-5p had indicatively significant positive 
association and miR-10b-5p indicatively significant negative association with E2 concentration (P = 0.025, 
FDR = 0.066 for both associations). Although only the six mentioned miRs possessed significant association with 
FDR < 0.05, it is clear from the heatmap that the miRs under investigation form two separate clusters the other 
cluster being indicative of positive and the other of negative health outcomes.
PREMENOPAUSAL 
(N = 8)
POSTMENOPAUSAL NO 
HRT (N = 10)
POSTMENOPAUSAL 
HRT (N = 10)
SIGNIFICANT 
COMPARISON (P < 0.05)
Age (yrs) 32.0 ± 1.6 57.5 ± 2.0 57.5 ± 2.0 a, b
Height (cm) 164.5 ± 4.0 162.2 ± 4.5 162.8 ± 4.7
Weight (kg) 70.0 ± 11.3 74.7 ± 15.6 67.8 ± 9.1
BMI 25.9 ± 4.5 28.6 ± 6.8 25.7 ± 4.0
Waist (cm) 86.4 ± 10.4 104.7 ± 9.6 100.9 ± 6.4 a, b
Fat % 29.7 ± 7.0 35.3 ± 9.3 30.5 ± 7.5 c
hsCRP (mg/l) 0.88 ± 1.1 1.53 ± 0.94 1.09 ± 0.95
IL-10 (pg/ml) 0.89 ± 1.7 2.50 ± 3.70 2.43 ± 3.17
IL-6 (pg/ml) 1.05 ± 0.70 1.77 ± 1.29 1.39 ± 0.71
TNFa (pg/ml) 6.1 ± 1.6 10.5 ± 2.3 10.7 ± 4.8 a, b
WBC (e9/l) 6.1 ± 1.2 5.2 ± 1.4 5.3 ± 1.3
RBC (e12/l) 4.5 ± 0.2 4.3 ± 0.3 4.4 ± 0.3
HGB (g/l) 139 ± 5.0 137 ± 9.4 140 ± 9.1
Plt (e9/l) 242.8 ± 54.2 233.9 ± 39.1 236.8 ± 83.4
Chol (mmol/l) 4.7 ± 0.8 5.3 ± 0.4 5.3 ± 0.7
LDL (mmol/l) 2.7 ± 0.8 3.1 ± 0.4 3.1 ± 0.8
HDL (mmol/l) 1.6 ± 0.4 1.6 ± 0.4 1.6 ± 0.5
TriGly (mmol/l) 0.8 ± 0.2 1.2 ± 0.5 1.2 ± 1.0
Adiponectin (ng/ml) 7432 ± 3606 9382 ± 5273 10267 ± 5350
Leptin (pg/ml) 23225 ± 10977 18571 ± 13705 12483 ± 8672
Resistin (ng/ml) 9.4 ± 2.0 10.2 ± 1.2 9.7 ± 1.4
Ins (mmol/l) 5.3 ± 3.3 8.0 ± 4.5 6.2 ± 3.6
Gluc (mmol/l, plasma) 4.2 ± 0.4 5.2 ± 0.7 5.0 ± 0.7 a, b
E2 (pmol/l) 496.5 ± 311.9 34.8 ± 28.4 183.0 ± 211.3 a#, b#, c#
E1 (pmol/l) 369.4 ± 195.3 100.9 ± 26.0 962.0 ± 1517.8 a#, c#
T (nmol/l) 1.02 ± 0.30 0.66 ± 0.27 0.74 ± 0.31 a, c
SHGB (nmol/l) 49.3 ± 17.6 44.1 ± 11.6 72.3 ± 31.1 c
LH (IUl) 12.8 ± 13.2 39.9 ± 30.2 31.6 ± 17.3 a#, b#
FSH (IUl) 6.22 ± 2.85 83.7 ± 32.7 57.0 ± 31.2 a, b, c
Table 1. Participant body anthropometrics and blood characteristics and differences between the studied 
groups. Significant comparisons between the studied groups are marked with letters a) Pre vs post No HRT b) 
Pre vs post HRT c) Post HRT vs post No HRT. Independent samples T-test was used for a and b comparisons 
and paired samples T-test for c comparisons when variables were parametric. #Mann Whitney U test (a and b) 
and Wilcoxon matched pair signed-rank test (c) was used for non-parametric variables. P < 0.05 was considered 
significant. Results are shown as mean ± S.D. BMI: body mass index, hsCRP: high sensitive c-reactive protein, 
IL-10: interleukin 10, IL-6: interleukin 6, TNFa: tumor necrosis factor alpha WBC: white blood cell count, RBC: 
red blood cell count, HGB: hemoglobin, Plt: platelet, Chol: cholesterol, LDL: low density lipoprotein, HDL: high 
density lipoprotein, TriGly: triglycerides, E2: 17β -estradiol, E1: estrone, T: testosterone, SHGB: sex hormone-
binding globulin, LH: lutenizing hormone, FSH: follicle stimulating hormone.
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The positive health outcome cluster miRs had positive associations with E2 and the negative health outcome 
cluster miRs had negative associations with E2 and concomitant negative and positive associations, respectively, 
with most of the adiposity and inflammation related variables except that with HDL and adiponectin which were 
clustered together with E2 concentration. However, the associations with miRs and HDL count were only indic-
atively significant for miR-148a-3p and -27b-3p with HDL (P = 0.009, FDR = 0.126 and P = 0.012, FDR = 0.126, 
respectively) and for miR-27b-3p with adiponectin (P = 0.013, FDR = 0.273) while for the other miRs the associa-
tions were non-significant. The leading miRs for the negative health outcome cluster were miR-27b-3p, which had 
the highest number of significant associations and miR-148a-3p, which had very similar profile although some 
of the associations were only nominally significant. The higher NGS read count value of miR-27b-3p was signif-
icantly associated (FDR < 0.05) with greater adiposity (fat percentage, BMI, waist circumference, triglyceride 
concentration), with higher fasting glucose and insulin and with higher hsCRP, resistin and TNF-α (P = 0.014, 
FDR = 0.095) together with lower E2 concentration. The positive health outcome cluster did not have as prom-
inent leading miR, but the miRs having positive association with E2, miR-106b-5p and miR-144-5p, had also 
negative association with TNF-α (P = 0.027, FDR = 0.099 and P = 0.008, FDR = 0.084, respectively). In addition, 
miR-106b-5p, -532-5p and -484 had statistically significant (FDR < 0.05) negative associations with resistin.
Validation of differentially expressed sequenced miRs. qPCR validations of the E2-associated miRs 
are presented in Fig. 6. For miR-27b-3p, -148a-3p and -126-5p the levels were significantly lower in premeno-
pausal women compared to postmenopausal No HRT group (P = 0.001, P = 0.001, P = 0.040, respectively) and 
Figure 1. Electron microscope image of the extracted serum vesicles. Typical size of an exosome is less than 
100 nm in diameter. A Tecnai G2 Spirit transmission electron microscope (FEI, Eindhoven, The Netherlands).
Figure 2. Relative serum exomiR content of all the samples. 
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HRT group (P = 0.005, P = 0.040, P = 0.005, respectively). MiR-106b-5p was significantly lower in premenopau-
sal women compared to postmenopausal HRT group (P = 0.040) and lower in No HRT women compared to their 
HRT co-twins (P = 0.043). No differences between any groups were detected for miR-28-3p and -30a-5p (data 
not shown).
Discussion
This is the first study showing that age and the use of HRT are associated with the miR contents of the circulating 
exosomes in women. Altogether, 241 distinct known serum exomiRs were detected by NGS among the studied 
groups from which 21 were differentially expressed. The NGS results showed that exomiR -levels differ between 
all of the three studied groups significantly in cases of four miRs. In addition, age-associated difference without 
HRT was detected in six miRs (postmenopausal No HRT vs premenopausal), and with HRT in ten miRs (post-
menopausal HRT vs premenopausal) as well as treatment difference in ten miRs (postmenopausal HRT vs No 
HRT).
Menopause is recognized as a risk factor for the development of metabolic dysfunctions16,17. The loss of circu-
lating E2 is followed by androgen dominance and further by body fat accumulation around the abdominal area18. 
The excess amount of adipose tissue leads to unbalanced cytokine profile which is seen as increased levels of IL-6, 
TNF-α , IL-1β , resistin and leptin among other inflammatory molecules19. These circulating pro-inflammatory 
cytokines form a base for systemic low-grade inflammation also known to be associated with aging20. In addition 
to adipose tissue initiated release of pro-inflammatory cytokines, also issues in glucose metabolism, such as insu-
lin resistance play a role in the systemic inflammation21. Furthermore, endothelic dysfunction and atherosclerosis 
are adding to the chronic inflammatory state22. In our study the premenopausal women had healthier profile in 
terms of metabolic measures such as waist circumference and plasma glucose levels compared to postmenopausal 
women. In addition, fat percentage was significantly higher among the postmenopausal women who were not 
under HRT compared to their co-twins under HRT. We were able to see a slight increase in TNF-α levels due 
to age, whether under HRT or not, but no significant differences in other classical pro-inflammatory markers 
between any of the studied groups. However, across the measured inflammatory markers a trend towards the 
most unbeneficial state was detected among postmenopausal women, who were not under HRT. Clear expected 
differences were detected in systemic steroid hormone levels as well as gonadotropins, from which high FSH 
levels are indicators of postmenopausal state. In addition, interesting associations with serum E2 concentrations 
and differentially expressed miRs, inflammation, glucose metabolism and adiposity -related markers were found.
The present study revealed six different miRs which were associated (FDR < 0.05) with serum E2 levels either 
positively (miR-106b-5p) or negatively (miR-148a-3p, -27-3p, -126-5p, -28-3p and -30a-5p). In addition, two 
miRs had indicatively positive (miR-144-5p, P < 0.05) and negative (miR-10b-6p, P < 0.05) association with 
miR Pre
Mean count
Overdispersion
Comparison (p-value, FDR)
No 
HRT HRT No HRT vs. Pre
HRT vs. 
Pre
HRT vs. 
No HRT
miR-126-5p 3942 5822 5601 0.002 < 0.001↑ < 0.001↑ < 0.001↓
miR-142-5p 10591 6254 6669 0.007 < 0.001↓ < 0.001↓ < 0.001↑
miR-484 2106 1201 1471 0.029 < 0.001↓ < 0.001↓ < 0.001↑
miR-10b-5p 8535 6958 5323 0.007 < 0.001↓ < 0.001↓ < 0.001↓
miR-532-5p 395 263 356 0.102 0.184 1 < 0.001↑
miR-1285-3p 72 40 97 1.28 1 1 < 0.001↑
miR-30a-5p 1121 1880 1485 0.101 0.065 1 0.001↓
miR-3688-3p 6 4 10 6.248 1 1 0.016↑
miR-29b-3p 0 6 17 6.436 0.934 0.494 0.029↑
miR-106b-5p 399 219 333 0.155 0.118 1 0.029↑
miR-29c-3p 174 154 209 0.201 1 1 0.033↑
miR-1306-5p 4 2 5 4.692 1 1 0.036 ↑
miR-148a-3p 2095 3863 2814 0.094 0.008 ↑ 1 0.049↓
miR-301a-3p 12 38 22 2.061 1 1 0.049↓
miR-375 1056 629 329 0.482 1 0.045↓ 0.115
miR-28-3p 319 607 443 0.103 0.009↑ 1 0.275
miR-27b-3p 3307 8419 7025 0.034 < 0.001↑ < 0.001↑ 0.325
miR-10a-5p 3958 7682 6252 0.029 < 0.001↑ < 0.001↑ 0.671
miR-215-5p 190 1010 592 0.151 < 0.001↑ < 0.001↑ 0.671
miR-144-5p 585 375 433 0.034 < 0.001↓ < 0.001↓ 1
miR-186-5p 2056 2362 2598 0.026 0.063 < 0.001↑ 1
Table 2.  Read counts of the differentially expressed miRs based on sequencing results. The average read 
counts of the studied groups are presented on the left (Pre: premenopausal women, HRT: postmenopausal 
hormone replacement therapy users, No HRT: postmenopausal non-users). FDR corrected group comparisons 
are presented on the right. Arrow head pointing up indicates upregulation and arrow head pointing down 
downregulation in the first group of the comparison. Overdispersion is a measure of a greater variability.
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Figure 3. The most prominent network from IPA comparison analyses performed to all sequenced miRs. 
Differentially expressed miRs (FDR) are highlighted in the figure with coral colour. The arrow head of the red 
line tells the direction of the predicted affect. Blue line represents the predicted inhibition. Insulin is highlighted 
in yellow and ESR in pink. Smad2/3: Smad family member 2 or 3, Ras: protein superfamily of small GTPases, 
MAPK2K1/2: Mitogen activated protein kinase 2K1 or 2, FSH: Follicle stimulating hormone, Cg: Chorionic 
gonadotrophin, VEGF: Vascular endothelial growth factor, IL12: Interleukin 12, ERK1/2: Extracellular signal 
regulated kinase 1 or 2, SYPL1: Synaptophysin like 1. SLC38A1: Solute carrier family 38 member 1, Clorf56: 
Chromosome 1 open reading frame 56 solute, Jnk: Jun kinase, FNDC3A: fibronectin type III domain  
containing 3A.
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serum E2. To our knowledge two of these miRs have been previously shown to have an association with E2 in 
breast cancer cells. Nassa et al.23 have demonstrated that miR-30a-5p is regulated by estrogen receptor β (ESRβ ) 
whereas Tao et al.24 demonstrated that miR-148a is downregulated by E2 through GPER in breast cancer cells. In 
addition, 17-β -estradiol–ESRα –miR-27b -connection has been demonstrated on human leukemia cell line25. Our 
NGS data indicated significant differences between postmenopausal twins for miR-30a-5p and between all the 
studied groups for miR-148a-3p and miR-27b-3p. All miRs had a negative association with serum E2 which is in 
line with the mentioned studies.
Based on recent publications, some of the E2 associated miRs identified in the present study have connections 
to aging. MiR-10b-5p has been shown to be associated with the motor onset in both Parkinson’s and Huntington’s 
diseases26 indicating its function in the development of age-associated neurodegenerative disorders. Also, the 
role of circulating miR-10b-5p in osteogenic differentiation after fracture at postmenopausal age has been rec-
ognized27. In addition, changes in miR-28-3p levels during early senescence were observed in endothelial cells, 
thus, indicating miR’s possible regulatory role in the aging of vascular endothelium. Even though no direct effect 
of E2 has been stated in the mentioned studies, it has been well demonstrated that estrogen has a role as a neuro-, 
osteo- and vascular protector28–31. Our earlier studies have also shown beneficial effects of postmenopausal HRT 
on body composition measures, including fat, muscle and bone properties32–36. The connection between lipopro-
teins, vascular inflammation and exosomes has also been recognized by others37. MiR-27b-3p has been shown to 
regulate fat metabolism and inflammation by targeting RXRα and PPARγ 38,39. In the present study, mir-27b-3p 
was one of the most interesting single miRs belonging to the negative outcome cluster. The NGS data indicated 
higher levels of mir-27b-3p in the circulating exosomes of the postmenopausal twins compared to premenopausal 
Figure 4. IPA comparison analysis of the 3 different comparisons for differentially expressed miRs. The 
figure shows miRs in each comparison predicted to regulate cell proliferation. Red color indicates activation, 
blue inhibition and yellow controversial findings of the specific miR. Younger age and the use of HRT were 
predicted to inhibit the cell proliferation. The table shows the main networks for differentially ex-pressed 
miRs identified by IPA with its annotation as the top diseases and functions and the interacting molecules i.e., 
potential miR targets as well as miRs included in the network. The underlined miR targets are also involved in 
cell proliferation (figure).
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women indicating an age association. This miR was negatively associated with serum E2, HDL and adiponectin 
(last 2 nominal) whereas positive associations were detected with other adiposity markers such as fat percentage 
and triglycerides and nominally with LDL. In addition, the levels of miR-27b-3p were positively associated with 
serum hsCRP and resistin as well as insulin and plasma glucose concentrations, all of these markers indicative of 
unbeneficial metabolic and inflammatory status. The associations for miR-148a-3p were similar to miR-27b-3p 
but only nominally significant in some cases. Altogether, these results support the function of miR-27b-3p (and 
miR-148a-3p) in the regulation of lipid and glucose metabolism and further reveal its possible negative role in 
women’s aging with hormonal changes.
Different miR carrier systems share a bunch of common miRs but they also seem to have a unique content 
which differs from the other miR vehicles and, also, from the cell of origin40. Exosomes have been shown to 
deliver gene-based intercellular messages adding to the complexity of cell-cell communication. According to 
Cheng et al.41, exosomes provide a protected and enriched environment for miRs compared to the intracellular 
and other cell free miRs. In their study, exosome derived miRs were associated with neuronal signaling whereas 
the main responsibility of the cell free miRs was the signaling related to the cellular homeostasis, emphasizing 
the functional differences between cell free miRs and exomiRs. In our previous studies, we have shown that the 
circulating cell free levels of miR-21 and miR-146a differ between the HRT users and their non-using co-twins14. 
In the present study, we were able to detect the same miRs in the exosomes by NGS, however, significant differ-
ences were not obtained. That may be considered as a supporting indicator of the differential roles of the two 
types of miR transfer. The mechanism how the exomiRs are sorted into the exported exosomes is an unanswered 
question. It is under active speculation whether the sorting takes place by the miR sequence or whether the 
exomiR content is a description of the whole miR pool of the exosome forming cell. It is important to recognize 
that the sequencing data can be interpreted by several ways: one could either focus on the profile as a whole and 
compare the relative amounts and changes in the relative patterns, or the other option is to focus on specific miRs. 
Validation of specific miRs is not inevitably the whole truth as very often miRs work as a group fine-tuning each 
other’s function. In the present study, qPCR validation of the six E2-associated miRs confirmed the NGS results 
fully for miR-27b-3p and miR-126-5p and partly for miR-148a-3p and miR-106b-3p, however, no differences for 
miR-28-3p and -30a-5p were detected.
According to the functional network analyses obtained by IPA, the most prominent predicted upstream reg-
ulators of the studied miRs include insulin as well as estrogen receptors. These results support the link between 
the systemic E2 levels, insulin signaling and the studied miRs. In the comparison analyses performed using only 
the differentially expressed miRs, the cell proliferation processes were predicted to be inactivated at younger age 
as well as due to the use of HRT. Interestingly, different set of miRs seem to regulate cell proliferation processes 
depending on whether comparing only postmenopausal twins or premenopausal and postmenopausal women. 
Cell proliferation is usually considered to be more active at younger age. However, as we do not know the cell ori-
gin or destination of the exomiRs, we cannot say much about the specific processes and cells under the influence. 
Based on the present findings, the predicted activation of cell proliferation especially among the postmenopausal 
Figure 5. Clustered heatmap of the selected miRs and other measured variables. Blue indicates positive 
and red negative associations. Spearman correlation coefficient was used for the analyses. *P < 0.05 (nominal), 
**P < 0.05 (FDR corrected). Positive health outcome cluster is on the left side with positive associations with 
E2 and negative health outcome cluster on the right side with negative E2 associations. BMI: body mass index, 
TriGly: triglycerides Gluc: plasma glucose, Ins: serum insulin, hsCRP: high sensitive c-reactive protein, IL-6: 
interleukin 6, LDL: low densi-ty lipoprotein, TNFa: tumour necrosis factor alpha, IL-10: interleukin 10, Chol: 
cholesterol, WBC: white blood cell count, HDL: high density lipoprotein, E2: 17β -estradiol. RStudio Team 
(2015). RStudio: Integrated Development for R. RStudio, Inc., Boston, MA URL http://www.rstudio.com/.
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women without HRT, could be related to increasing amounts of adiposity, inflammatory cells or possibly tumor 
cells, all related to natural aging. These results suggest that the postmenopausal HRT users are more similar to 
premenopausal women in terms of miR regulated cell proliferation than postmenopausal non-users. Based on 
this genetically controlled study, these effects are achieved to most part by the HRT usage. The study has been per-
formed with a small unique population and thus cannot be generalized directly to female population as a whole. 
However, as a MZ twin study, it provides a valuable genetically controlled design. Further cell culture experiments 
are needed in order to say more about the specific functions of HRT sensitive exomiRs on specific cell types.
The recent achieved technologies in molecular biology, including NGS, provide promising tools to discover 
the broad functions of miRs in both physiological and pathological conditions. To our knowledge, the present 
study was the first to show a detailed serum exomiR profile of women with different age and hormonal status. We 
demonstrated that the differential expression patterns were emphasized among exomiRs interplaying with cel-
lular homeostasis, glucose- and lipid metabolism as well as inflammation. Furthermore, we were able to identify 
miR groups related to more positive or negative health outcomes in which the systemic E2 concentration played 
a significant role as a divider. Our findings suggest that the serum exomiRs are sensitive to hormonal changes 
among women and carry important regulatory messages between cells. The results can be used as a directional 
starting point for the usage of miR signature, obtained by NGS, as a medical tool for prognostics and diagnostics 
in aging women. In addition, the miR signature can potentially be applied when evaluating the benefits of HRT 
usage and its individual suitability in personalized medicine.
Materials and Methods
Study design. The present study is part of the research project “Sarcopenia and Skeletal Muscle Adaptation 
to Postmenopausal Hypogonadism: Effects of Physical Activity and Hormone Replacement Therapy in Older 
Women–a Genetic and Molecular Biology Study on Physical Activity and Estrogen-related Pathways (SAWEs)”. A 
Figure 6. qPCR validation of the miRs associated with systemic E2. Pre: Premenopausal women, No HRT: 
Postmenopausal women without hormone replacement therapy, HRT: Postmenopausal women using HRT. 
*P < 0.05, **P < 0.01. Results are presented as mean relative ex-pressions + SD.
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more detailed design and the recruitment process of the SAWEs- study has been described previously42,43. Briefly, 
the study participants were recruited from the Finnish Twin Cohort (n = 13888 pairs)44. The invitation was sent 
only to women born in 1943-1952 (n = 537 pairs). To be able to take part in the study, both co-sisters needed 
to participate. This study included 15 MZ female twin pairs who had no contraindications, were discordant for 
the use of HRT (mean duration of HRT use 6.9 ± 4.1) and were willing to participate to the study. Five of the 
HRT users were using preparations containing only E2 (1-2 mg), six used estrogenic (1–2 mg)+ progestogenic 
compounds and four tibolone (2.5 mg) based treatment. Since the aim of the present study was to investigate the 
effects of E2 based HRT, tibolone based HRT users and their co-twins were excluded. Finally, 11 MZ twin pairs 
were included in the present study, however, the NGS read quality of one sample was not sufficient enough thus, 
this twin pair was excluded from the analysis. The number of participants is relatively small but comparable with 
other MZ co-twin studies45–47 and has enough statistical power to obtain clinically relevant results. No significant 
differences in physical activity levels (slightly modified Grimby scale48), daily energy intake (5-day diary) or 
smoking habits between the twins were identified. In addition, eight women aged 30 to 40 years with no use of 
hormonal contraceptives during the last 5 years, were included for the present study representing a premenopau-
sal group. Contraindications for participation were chronic musculoskeletal diseases, type 1 or 2 diabetes, mental 
disorders, asthma with oral glucocorticosteroid treatment, cancer, drug or alcohol abuse, and Crohn’s disease. 
High blood pressure was the only condition to which daily medication was used (HRT: n = 3, No HRT: n = 4). 
Other occasional medication included antihistamines, paracetamol and ibuprofein. Overall, the participants were 
considered as healthy women.
The study was conducted according to the guidelines of the Declaration of Helsinki and the protocol was 
approved by the Ethics Committee of the Central Finland Hospital District (E0606/06). Written informed consent 
was provided by the study participants prior the laboratory measurements.
Serum analyses. Whole blood samples were collected under standard fasting conditions from antecubital 
vein in a supine position. The samples of the premenopausal women were collected during the first five days of 
the menstrual cycle representing the lowest E2 concentrations. The blood was allowed to clot for 30 mins in room 
temperature followed by serum separation by centrifugation at 4000 rpm. All the samples were snap frozen and 
stored in − 70 °C in 0.5 ml aliquots.
Exosome isolation, imaging and RNA extraction. Serum exosomes were isolated from 450 μ l of 
sample by using Exoquick Exosome Precipitation Solution according to manufacturer’s protocol (#EXOQ5A-1, 
System Biosciences).
Electron microscopy was used for checking the size of the extracted vesicles. Briefly, the isolated exosomes 
were deposited on Formvar carbon-coated, glow-discharged grids. After 20 minutes, the grids were washed with 
PBS and exosomes were fixed in 1% glutaraldehyde for 5 minutes. After washing with distilled water the grids 
were stained with neutral uranylacetate and embedded in methylcellulose/uranyl acetate and examined in a 
Tecnai G2 Spirit transmission electron microscope (FEI, Eindhoven, The Netherlands). Images were captured 
by Quemesa CCD camera using iTEM software (Olympus Soft Imaging Solutions GMBH, Munster, Germany). 
FLUOROCET Ultrasensitive Exosome Quantitation Assay Kit (System BioSciences), measuring exosome esterase 
activity, was used to assess the exosome quantity in samples (4 per each studied group) according to manufac-
turer’s protocol. Briefly, the protein concentration of exosome-PBS -solution was measured using BCA protein 
method by Nanodrop (1000) using wavelength 562 nm. Equal volume of exosome preparation was loaded into 
each 96-well plate. Promega Glomax Multi + Detection system with fluorescence module was used for the meas-
urement (excitation = 525 nm, emission = 580 to 640 nm). Results are presented as relative fluorescence unit 
(RFU) per total protein content of the sample (RFU/μ g).
Total RNA extraction was performed by using Trisure reagent (Bioline) according to manufacturers’ instruc-
tions with slight modifications. Additional step was added to the homogenization step where 7 μ l of synthetic 
cel-miR-39 miR mimic (1,6 × 108 copies/μ l, Qiagen cat. no 219610) was added to each sample to serve as a 
spike-in control for monitoring the miR purification and amplification. Chloroform was used for the phase sep-
aration and 1 μ l of nuclease free glycogen (Glycogen RNA Grade, 20 mg/ml, Fermentas) for enhancing the RNA 
precipitation. RNA concentration was measured by Nanodrop 1000 (Thermo Scientific). Prior the library prepa-
ration RNA quality and recovery was checked by qPCR according to manufacturer’s protocol (Qiagen miScript 
Primer assays and II RT kit for cDNA synthesis and MiScript SYBR Green PCR Kit for RT-qPCR) from which the 
recovery of cel-miR-39 spike-in control (Ctmean = 24.9 ± 1.0) and miR-21-5p (Ctmean = 27.3 ± 1.3) was verified.
cDNA library preparation and small RNA sequencing. The small RNA libraries were prepared using 
TruSeq Small RNA Sample Preparation Kit (Illumina, USA) with multiplexing adapters. Following the TruSeq 
Small RNA Sample Preparation Kit user guide (Rev. E), the total RNA, including the small RNA fractions, were 
ligated to 5′ and 3′ adaptors sequentially before converted to cDNA by reverse transcription. cDNAs were ampli-
fied with PCR by using primers containing unique six base index sequences distinguishing different samples from 
one another. Finally, the samples were subjected to 6% (w/v) non-denaturing polyacrylamide gel electrophoresis 
(PAGE). cDNA library fragments between 145 and 160 bp corresponding the miR libraries were excised from the 
gel, purified and eluted. The final miR library pellet was air dried and resuspended in 10 μ L nuclease-free water 
and quantity of the libraries was measured with Qubit fluorometer. Ready miR library pools (8–16 samples on 
single pool) were loaded to MiSeq V3 flow cell in 12 pM concentrations. To increase signal integrity, 10% of PhiX 
was spiked in the library pool. MiR libraries were sequenced with MiSeq reagent kit V3 150 cycles using 36 bp 
reads with single-end chemistry. Three replicates were used in each NGS run.
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miR validation. The miRs having differential expression in NGS results and significant association with sys-
temic E2 (FDR < 0.05, Fig. 5) were validated with RT-qPCR. These miRs included miR-27b-3p, -148a-3p, -126-5p, 
-28-3p, -30a-5p and -106b-5p. Validation was performed using samples from five postmenopausal twin pairs and 
ten premenopausal women. MiScript II RT Kit was used for cDNA synthesis (Qiagen) according to manufacturer’s 
protocol. cDNA was diluted 1:3 for the RT-qPCR which was performed using miScript SYBR Green PCR Kit and 
miScript Primer assays (Qiagen: Cat. No. MS00031668, MS00003556, MS00006636, MS00009254, MS00007350, 
MS00003402, MS00019789) according to manufacturer’s protocol. Ct-values less than 36 were included in the 
analyses. Results were normalized to spike-in cel-miR-39 values of each sample (Ct(av) = 25.1 ± 1.0). A pooled 
calibrator sample was used across the different plates to obtain 2−dCt (= RQ) results. Subsequently, normalized 
relative quantities (NRQ) were calculated for each miR of each sample (NRQ = RQ/NF), where normalization 
factor (NF) presented the geometric mean of RQs of all expressed miRNAs per sample49.
Bioinformatics and statistical analyses. The workflow for cleaning and analyzing the sequencing results 
is presented in the Fig. 7. Briefly, quality of the raw reads was assessed with FastQC and reads were trimmed using 
cutadapt based on the FastQC ‘Overrepresented sequences’ module output and using a minimum read length fil-
ter of nine bases. Trimmed read files were analyzed with miRDeep2, a comprehensive computational tool for miR 
analysis and discovery which uses a probabilistic model of miR biogenesis to score compatibility of the position 
and frequency of sequenced RNA with the secondary structure of the miR precursor50. Mapping to the refer-
ence genome (hg38) was performed using bowtie (version 1.0.1) and miRbase version 18 was used for retrieving 
miR information. Differential expression analysis was performed on miRDeep2 output data utilizing a custom 
R script adapted from the differential expression module in the CAP-miRSEQ tool50,51. The tools employed in 
different steps rely on various programming languages. To simplify the workflow a set of R functions was created 
to carry out QC, trimming, miRDeep analysis and assessment of differential expression in a pipeline-like fashion 
run from one wrapper script. In addition, Poisson-normal regression model was created to analyze the related 
Figure 7. Workflow of the handling of the sequencing data. All the methods and R packages used in the 
analyses are presented in the figure.
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participants (unpublished manuscript). Briefly, read counts were modeled as Poisson distributed variables with 
over distribution modeled through a normally distributed random variable. The advantage of this model over e.g. 
the negative-binomial model is that it allows flexible modeling of dependency among related subjects through 
the random effect correlation matrix. The model was applied on each miR on MPlus version 7 and FDR approach 
was used to adjust for multiple testing. All other statistical computations were done in R software (versions 3.1.3–
3.3.1). R packages used in the bioinformatics workflow are mentioned in Fig. 7.
The group analyses are based on three groups: (1) premenopausal women (n = 8), (2) postmenopausal No 
HRT (n = 10) and (3) postmenopausal HRT users (n = 10), the latter two forming MZ twin pairs. Based on the 
normal distribution of the studied variables, tested by Shapiro-Wilk test, the group comparisons were performed 
either with Independent samples T test and paired samples T test (twins), in case of parametric variables, or with 
Mann Whitney U test and Wilcoxon signed-rank test (twins) in case of non-parametric variables. Two-sided tests 
were used. Ingenuity pathway analyses (IPA) tool was used for pathway and comparison analyses of all sequenced 
miRs and differentially expressed miRs. P < 0.05 was considered significant. Spearman’s rank correlation coeffi-
cient was used for correlation analyses and R packages “gplots” and “RColorBrewer” were used for creating the 
clustered heatmap (Fig. 5). Data analyses and visualizations were carried out using Eclipse IDE Luna (4.4.2) and 
the StatET plugin for R (3.4.2) with RJ 2.0, IBM SPSS Statistics (version 23.0, Chicago, IL) and R Studio (R Studio 
Team 2015, Boston, MA).
Data availability. The processed read counts are provided in the Supplemetary data (S1). The raw sequence 
read files are open at ArrayExpress database (www.ebi.ac.uk/arrayexpress) upon publication under access number 
E-MTAB-5245. Computer code availability is provided on request.
Limitations. The methods of sample collection, RNA extraction and further analyses are not yet standardized 
in NGS. The enzymatic steps in small RNA cDNA library preparation might favor certain miRs over others due 
to sequence-specific biases. However, same protocol was used across the study, therefore such bias would occur 
similarly in each sample and would not affect the results of the group comparisons. Also exosome extraction 
methods lack standardization.
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